↓ Skip to main content

Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium

Overview of attention for article published in PharmacoEconomics - Open, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
facebook
1 Facebook page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
52 Mendeley
Title
Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium
Published in
PharmacoEconomics - Open, January 2020
DOI 10.1007/s41669-019-00191-w
Pubmed ID
Authors

C. Rinciog, A. Diamantopoulos, A. Gentilini, B. Bondue, C. Dahlqvist, A. Froidure, W. A. Wuyts, S. Soulard

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Other 8 15%
Researcher 6 12%
Student > Bachelor 5 10%
Student > Ph. D. Student 5 10%
Student > Doctoral Student 3 6%
Other 7 13%
Unknown 18 35%
Readers by discipline Count As %
Medicine and Dentistry 14 27%
Pharmacology, Toxicology and Pharmaceutical Science 6 12%
Biochemistry, Genetics and Molecular Biology 2 4%
Unspecified 2 4%
Economics, Econometrics and Finance 2 4%
Other 9 17%
Unknown 17 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2020.
All research outputs
#4,213,663
of 23,186,937 outputs
Outputs from PharmacoEconomics - Open
#77
of 335 outputs
Outputs of similar age
#98,304
of 456,833 outputs
Outputs of similar age from PharmacoEconomics - Open
#3
of 12 outputs
Altmetric has tracked 23,186,937 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 335 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,833 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.